The creatine transporter (CRTR) defect is a recently discovered cause of X-linked intellectual disability for which treatment options have been explored. Creatine monotherapy has not proved effective, and the effect of treatment with L-arginine is still controversial. Nine boys between 8 months and 10 years old with molecularly confirmed CRTR defect were followed with repeated 1H-MRS and neuropsychological assessments during 4–6 years of combination treatment with creatine monohydrate, L-arginine, and glycine. Treatment did not lead to a significant increase in cerebral creatine content as observed with H1-MRS. After an initial improvement in locomotor and personal-social IQ subscales, no lasting clinical improvement was recorded. Additionally, we noticed an age-related decline in IQ subscales in boys affected with the CRTR defect.
Long-term follow-up and treatment in nine boys with X-linked creatine transporter defect
J. M. van de Kamp,P. Pouwels,Femke K Aarsen,L. T. Ten Hoopen,D. Knol,J. D. de Klerk,I. F. D. de Coo,J. Huijmans,C. Jakobs,M. S. van der Knaap,G. Salomons,G. Mancini
Published 2011 in Journal of Inherited Metabolic Disease
ABSTRACT
PUBLICATION RECORD
- Publication year
2011
- Venue
Journal of Inherited Metabolic Disease
- Publication date
2011-05-10
- Fields of study
Medicine
- Identifiers
- External record
- Source metadata
Semantic Scholar, PubMed
CITATION MAP
EXTRACTION MAP
CLAIMS
- No claims are published for this paper.
CONCEPTS
- No concepts are published for this paper.
REFERENCES
Showing 1-40 of 40 references · Page 1 of 1
CITED BY
Showing 1-60 of 60 citing papers · Page 1 of 1